Igland J, Forster R, Jenum AK, Strandberg RB, Berg TJ, Røssberg JI, Iversen MM, Buhl ES(2024) How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway BMJ Open, 14(3), e077027 DOI 10.1136/bmjopen-2023-077027, PubMed 38548358
Pietzner M, Uluvar B, Kolnes KJ, Jeppesen PB, Frivold SV, Skattebo Ø, Johansen EI, Skålhegg BS, Wojtaszewski JFP, Kolnes AJ, Yeo GSH, O'Rahilly S, Jensen J, Langenberg C(2024) Systemic proteome adaptions to 7-day complete caloric restriction in humans Nat Metab(in press) DOI 10.1038/s42255-024-01008-9, PubMed 38429390
Ruiz PL, Karlstad Ø, Nøkleby K, Slåtsve K, Gulseth HL, Meyer HE, Sveen KA, Qvigstad E, Furu K(2024) Pharmacological treatment of obesity in adults in Norway 2004-2022 Diabetes Obes Metab(in press) DOI 10.1111/dom.15515, PubMed 38419410